CMHSU: An R Statistical Software Package to Detect Mental Health Status, Substance Use Status, and Their Concurrent Status in the North American Healthcare Administrative Databases
Abstract
:1. Introduction
1.1. Concurrent Mental Health Status and Substance Use Status: Definition and Diagnosis
1.1.1. Comprehensive Clinical Assessment (CCA)
1.1.2. Standardized Screening Instruments (SSI)
1.1.3. Integrated Treatment Approach (ITA)
1.1.4. Multidisciplinary Collaboration (MC)
1.1.5. Data-Driven Diagnostic Method (DDDM)
- [a]
- at least one mental health (MH) diagnosis (defined by at least times hospitalizations or primary care physician visits within time span),
- [b]
- at least one substance use (SU) diagnosis (defined by at least times hospitalizations or primary care physician visits within time span).
1.2. North American Healthcare Administrative Databases
1.3. Motivation
- (i)
- Scalability and Large-Scale Analysis: The Data-Driven Diagnostic Method (DDDM) offers the advantage of scalability by utilizing healthcare databases and administrative records to analyze large populations. Unlike approaches that require direct patient interaction, DDDM enables the comprehensive assessment of co-occurring mental health and substance use status across diverse demographic groups and healthcare systems [23].
- (ii)
- Objective and Quantitative Approach: DDDM relies on the objective extraction and analysis of the data features such as ICD codes and patterns of healthcare utilization. This DDDM characteristic minimizes biases often associated with subjective methods, such as clinical interviews, thereby improving the reliability and validity of diagnostic outcomes [24].
- (iii)
- Cost-Effectiveness: By leveraging preexisting healthcare data, DDDM eliminates the need for resource-intensive procedures, such as in-person assessments or multidisciplinary team evaluations. This makes it a cost-efficient alternative for healthcare systems facing resource limitations [25].
- (iv)
- Timeliness and Accessibility: DDDM enables rapid identification of MHSU patterns through the querying of existing data sources, providing real-time or nearly real-time diagnostic capabilities. This characteristic is particularly valuable for tracking trends and addressing emerging public health issues [26].
- (v)
- Population-Level Insights for Policy and Planning: Through its capacity to analyze large-scale healthcare data, DDDM facilitates the identification of utilization trends, disparities, and service gaps. This characteristic allows policymakers to design targeted interventions and optimize resource allocation to address the needs of individuals with co-occurring status [24].
1.4. Study Outline
2. The CMHSU Package
2.1. The Background and Installation
- Line #1: > install.packages(‘‘CMHSU’’, dependencies=TRUE)
- Line #2: > library(CMHSU)
- (1) MH_status(),
- (2) SU_status(),
- (3) MHSU_status_basic(),
- (4) MHSU_status_broad.
2.2. Detection of Mental Health Status
- ClientID, which uniquely identifies the patient,
- VisitDate, indicating the date of the visit,
- Diagnostic_H, representing diagnoses made during hospital visits,
- Diagnostic_P, reflecting diagnoses made by medical service physicians.
2.3. Detection of Substance Use Status
- ClientID,
- VisitDate,
- Diagnostic_H,
- Diagnostic_P.
2.4. Detection of Concurrent Mental Health and Substance Use (MHSU) Status—Part (I)
- inputdata (dataframe with ClientID, VisitDate, Diagnostic_H, Diagnostic_P),
- n_MHH,
- n_MHP,
- n_SUH,
- n_SUP,
- t_MH,
- t_SU,
- t_MHSU,
- ICD_MH,
- ICD_SU.
2.5. Detection of Concurrent Mental Health and Substance Use (MHSU) Status—Part (II)
3. A Simulation Study
3.1. Simulated Real-World Data
- The dataset consists of 200 patients categorized into seven diagnostic groups who visited hospitals or medical service physicians from 1 January 2024, to 31 December 2024.
- The patient groups include 125 individuals with recorded mental health (MH) diagnoses, 125 with substance use (SU) diagnoses, 100 with concurrent MHSU diagnoses, and 50 with no MH, SU, or MHSU diagnoses.
3.2. The Impact of Maximum Time Span Within Mental Health and Within Substance Use
3.3. The Impact of Number of Hospital Visits and Medical Service Physician Visits
3.4. The Impact of Maximum Time Span for Concurrent Diagnosis
3.5. Temporal Analysis
4. Discussion
4.1. Summary and Contributions
- Dimension of Time Spans within MH Diagnosis and SU Diagnosis (Section 3.2): The time spans within MH and SU diagnoses play a critical role. For instance, if a maximum time span of 7 days is considered, only 48 out of 100 patients (48.8%) are captured, whereas extending the time span to 56 days captures 90 out of 100 patients (90.0%). This delicate situation raises the question: “What are the appropriate maximum time spans for MH and SU diagnoses?”
- Dimension of Required Number of Visits (Section 3.3): The number of required hospital and medical service physician visits significantly influences the detection rates. For example, requiring two hospital visits and four physician visits captures 90 out of 100 patients (90.0%), while increasing the required threshold to three hospital visits and six physician visits reduces the capture rate to 70 out of 100 patients (70.0%). This delicate balance prompts the question: “What is the optimal minimum number (or ratio) of required visits?”
- Dimension of Time Span for Concurrent (MHSU) Status (Section 3.4): The maximum time span between MH and SU diagnoses also plays a vital role in the detection. For instance, setting this span to one month captures 61 out of 100 patients (61.0%), while extending it to three months captures 84 out of 100 patients (84.0%). This scenario raises the question: “What is the ideal maximum time span between MH and SU diagnoses?”
4.2. Strengths, Limitations, and Future Work
- Flexibility: CMHSU incorporates four core functions and ten customizable parameters, allowing researchers to account for a wide range of predefined scenarios by investigators when identifying MH status, SU status, and MHSU status in the healthcare administrative databases.
- Comprehensiveness: CMHSU enables the detection of nearly all mental health and substance use conditions, providing an advantage over other statistical tools, particularly given the recent comprehensive codifications in ICD-10 and ICD-11.
- Efficiency: The CMHSU package is designed for ease of use, requiring only a basic statistical background. Unlike advanced statistical and machine learning-based detection methods for MH status [39], SU status [40], and MHSU status [41]—which typically necessitate expertise in topics such as K-Nearest Neighbors, Random Forests, Gradient Boosted Trees, Deep Neural Networks—CMHSU offers a user-friendly and time-efficient alternative statistical software tool. This advantage makes it a particularly accessible and practical tool for researchers and practitioners without extensive statistical or machine learning expertise.
- Interpretability: CMHSU employs a trace-back methodology to identify MH status, SU status, and MHSU status based on their corresponding ICD codes. This approach enhances the clarity and transparency of the results, facilitating faster interpretation, improved visualization of detected cases, and analysis of trends over time compared to other statistical tools.
- Seamless Integration: The package is free and easy to install, ensuring compatibility with existing analytical tools used for processing large healthcare administrative databases. This seamless integration enhances its accessibility and usability in the real-world research applications.
- Scalability: For large-scale databases, it may be more efficient to partition the input dataset into multiple disjoint subsets and apply the MHSU_status_broad() function to each subset separately to manage the extensive outputs. Introducing an additional parameter within the function to automate the partitioning of the input data (inputdata) would further optimize the computational process (See Appendix A.1).
- Output Format: The package currently generates outputs as dataframes only, without providing summary frequency statistics for mental health status, substance use status, and their concurrent status. Calculating these statistics requires additional R programming (See Appendix A.2).
- Customization: The window lag in the function MHSU_status_broad() is fixed at one day (as illustrated in Figure 3). Adding a fixed or adaptive parameter to specify the length of this window lag would enhance the flexibility of the detection process for researchers. The choice of fixed or adaptive status depends to the specific patient data in the study.
- Evaluation: The DDDM approach assumes that ICD coding in administrative databases is reliable. However, in practice, these records are often incomplete or subject to misclassifications, leading to potential biases in the evaluation process and, consequently, affecting the accuracy of the results. Furthermore, it is still unclear how to measure the package’s precision performance in detecting patients with MH status, SU status, and MHSU status, as well as how to compare its performance using DDDM with more advanced machine learning-based methods [39,40,41]. This comparison needs a mapping mechanism between the above parameters in the DDDM and above machine learning-based methods requiring subsequent methodological research.
- Standardization: The use of ICD codes for diagnosis depends on the local and national jurisdictions (Table 1). Potential inconsistencies in coding across different jurisdictions and healthcare databases may affect the reliability of the results for comparisons across these jurisdictions.
- Empirical Validation: The simulation study presented in this paper utilizes self-generated simulated data. Ideally, using a real-life empirical healthcare administrative database would significantly enhance the validity and applicability of the findings for healthcare policy implementations. However, key obstacles—including (1) data privacy and security regulations, (2) access restrictions and bureaucratic hurdles, and (3) selection bias—prevented the use of such a database in the current analysis.
- Geographical Adaptability: CMHSU is designed for detecting mental health (MH) status, substance use (SU) status, and their concurrent (MHSU) status within the North American healthcare databases, based on the fact that the original DDDM was developed by researchers in this region. However, it remains unclear whether these methods can be effectively adopted for use in the non-North American healthcare systems, given potential differences in healthcare infrastructure, coding practices, and administrative data structures. Despite all these issues, given availability of the essential data fields, a preliminary analysis is still possible (See Section 4.3).
- Temporal Analysis: The simulation study in this paper serves as a hypothetical demonstration of the package’s application. Its results can only be truly meaningful and applicable to real-world policymaking if the DDDM parameters are based on a universally agreed-upon set of predefined values related to time span and visit definitions. However, no such universally accepted standard parameters currently exist among psychiatrists. Addressing this issue requires further discussions, research, and a final systematic review and meta-analysis among various studies.
4.3. Summary of CMHSU Data Analysis Workflow
- (i)
- Compile CMHSU Data:Gather essential data fields, including ClientID, VisitDate, Diagnostic_H, and Diagnostic_P.
- (ii)
- Assess Scalability:
- (a)
- Size: Execute data size scalability by applying the function splitfunction_id().
- (b)
- Time: Execute temporal scalability by applying the function splitfunction_time().
- (iii)
- Define Analysis Parameters:Specify required parameters, such as n_MHH, n_MHP, and others as necessary.
- (iv)
- Examine Data Time Span:
- (a)
- For data spans less than or equal to t_MHSU, apply the function MHSU_status_basic().
- (b)
- For data spans exceeding t_MHSU, apply the function MHSU_status_broad().
- (v)
- Report Results:
- (a)
- Frequency: Extract count data using the script SummarySampleMHSU_1.
- (b)
- Proportion: Extract proportion data using the script SummarySampleMHSU_1.
- (vi)
- Temporal Interpretation:Interpret temporal patterns by applying the [Unit, Span] methodology illustrated in Section 3.5.
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
Appendix A
Appendix A.1. Scalability with Large Databases
Appendix A.2. Summary Statistics Output
References
- Weiss, K.J.; Rosenberg, D.J. Prevalence of anxiety disorder among alcoholics. J. Clin. Psychiatry 1985, 46, 3–5. [Google Scholar] [PubMed]
- Jaffe, J.H.; Ciraulo, D.A. Alcoholism and depression. In Psychopathology and Addictive Disorders; Meyer, R.E., Ed.; Guilford Press: New York, NY, USA, 1986. [Google Scholar]
- Helzer, J.E.; Pryzbeck, T.R. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J. Stud. Alcohol 1988, 49, 219–224. [Google Scholar] [CrossRef] [PubMed]
- Drake, R.E.; Wallach, M.A. Substance abuse among the chronic mentally ill. Hosp. Community Psychiatry 1989, 40, 1041–1046. [Google Scholar] [CrossRef] [PubMed]
- Regier, D.A.; Farmer, M.E.; Rae, D.S.; Locke, B.Z.; Keith, S.J.; Judd, L.L.; Goodwin, F.K. Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990, 264, 2511–2518. [Google Scholar] [CrossRef]
- Drake, R.E.; Wallach, M.A. Moderate drinking among people with severe mental illness. Hosp. Community Psychiatry 1993, 44, 780–782. [Google Scholar] [CrossRef]
- Kessler, R.C.; McGonagle, K.A.; Zhao, S.; Nelson, C.B.; Hughes, M.; Eshleman, S.; Wittchen, H.U.; Kendler, K.S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Arch. Gen. Psychiatry 1994, 51, 8–19. [Google Scholar] [CrossRef]
- Wright, S.; Gournay, K.; Glorney, E.; Thornicroft, G. Dual diagnosis in the suburbs: Prevalence, need, and in-patient service use. Soc. Psychiatry Psychiatr. Epidemiol. 2000, 35, 297–304. [Google Scholar] [CrossRef]
- Evans, K.; Sullivan, M.J. Dual Diagnosis: Counseling the Mentally Ill Substance Abuser; Guilford Press: New York, NY, USA, 2001. [Google Scholar]
- Cantwell, R. Substance use and schizophrenia: Effects on symptoms, social functioning, and service use. Br. J. Psychiatry 2003, 182, 324–329. [Google Scholar] [CrossRef]
- Blanco, C.; Alegría, A.A.; Liu, S.M.; Secades-Villa, R.; Sugaya, L.; Davies, C. Differences among major depressive disorder with and without co-occurring substance use disorders and substance-induced depressive disorder. J. Clin. Psychiatry 2012, 73, 865–873. [Google Scholar] [CrossRef]
- Szerman, N.; Martinez-Raga, J.; Peris, L. Rethinking dual disorders. Addict. Disord. Their Treat. 2012, 11, 191–200. [Google Scholar] [CrossRef]
- Atkins, C. Co-Occurring Disorders: Integrated Assessment and Treatment of Substance Use and Mental Disorders; PESI Publishing & Media: Eau Claire, WI, USA, 2014. [Google Scholar]
- Todd, J.; Green, G.; Harrison, M.; Ikuesan, B.A.; Self, C.; Baldacchino, A.; Sherwood, S. The challenges of dual diagnosis: Substance misuse and psychiatric disorders. J. Psychiatr. Ment. Health Nurs. 2004, 11, 48–54. [Google Scholar] [CrossRef] [PubMed]
- Mueser, K.T.; Noordsy, D.L.; Drake, R.E.; Fox, L. Integrated Treatment for Dual Disorders: A Guide to Effective Practice; Guilford Press: New York, NY, USA, 2003. [Google Scholar]
- Sciacca, K. On co-occurring addictive and mental disorders: A brief history of the origins of dual diagnosis treatment and program development. Am. J. Orthopsychiatry 1996, 66, 407–413. [Google Scholar] [CrossRef] [PubMed]
- Skinner, H.A. The Drug Abuse Screening Test. Addict. Behav. 1982, 7, 363–371. [Google Scholar] [CrossRef] [PubMed]
- Babor, T.F.; Higgins-Biddle, J.C.; Saunders, J.B.; Monteiro, M.G. AUDIT: The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care, 2nd ed.; World Health Organization: Geneva, Switzerland, 2001. [Google Scholar]
- Drake, R.E.; O’Neal, E.L.; Wallach, M.A. A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. J. Subst. Abus. Treat. 2008, 34, 123–138. [Google Scholar] [CrossRef]
- Minkoff, K. Best practices: Developing standards of care for individuals with co-occurring psychiatric and substance use disorders. Psychiatr. Serv. 2001, 52, 597–599. [Google Scholar] [CrossRef]
- Sterling, S.; Chi, F.; Hinman, A. Integrating care for people with co-occurring alcohol and other drug, medical, and mental health conditions. Alcohol Res. Health 2011, 33, 338–349. [Google Scholar]
- Mueser, K.T.; Fox, L. A family intervention program for dual disorders. Community Ment. Health J. 2002, 38, 253–270. [Google Scholar] [CrossRef]
- Heslin, K.C.; Weiss, A.J. Hospitalizations Involving Mental and Substance Use Disorders Among Adults; Agency for Healthcare Research and Quality (AHRQ): Rockville, MD, USA, 2015. Available online: https://www.hcup-us.ahrq.gov (accessed on 3 January 2025).
- Keen, C.; Kinner, S.A.; Young, J.T.; Jang, K.; Gan, W.; Samji, H.; Zhao, B.; Krausz, M.; Slaunwhite, A. Prevalence of co-occurring mental illness and substance use disorder and association with overdose: A linked data cohort study among residents of British Columbia, Canada. Addiction 2022, 117, 129–140. [Google Scholar] [CrossRef]
- Lavergne, M.R.; Shirmaleki, M.; Loyal, J.P.; Jones, W.; Nicholls, T.L.; Schütz, C.G.; Vaughan, A.; Samji, H.; Puyat, J.H.; Kaoser, R.; et al. Emergency department use for mental and substance use disorders: Descriptive analysis of population-based, linked administrative data in British Columbia, Canada. BMJ Open 2022, 12, e057072. [Google Scholar] [CrossRef]
- Lavergne, M.R.; Loyal, J.P.; Shirmaleki, M.; Kaoser, R.; Nicholls, T.; Schütz, C.G.; Vaughan, A.; Samji, H.; Puyat, J.H.; Kaulius, M.; et al. The relationship between outpatient service use and emergency department visits among people treated for mental and substance use disorders: Analysis of population-based administrative data in British Columbia, Canada. BMC Health Serv. Res. 2022, 22, 477. [Google Scholar] [CrossRef]
- Khan, S. Concurrent mental and substance use disorders in Canada. Health Rep. 2017, 28, 3–8. Available online: https://www.statcan.gc.ca (accessed on 3 January 2025). [PubMed]
- Health Canada. Best Practices: Concurrent Mental Health and Substance Use Disorders; Centre for Addiction and Mental Health: Ottawa, ON, Canada, 2002; Available online: https://publications.gc.ca/site/eng/247253/publication.html (accessed on 3 January 2025).
- Alberta Health Services. Enhancing Concurrent Capability Across Addiction and Mental Health Services: Foundational Concepts; Alberta Health Services: Edmonton, AB, Canada, 2011; Available online: https://www.albertahealthservices.ca (accessed on 3 January 2025).
- World Health Organization. International Classification of Diseases for Mortality and Morbidity Statistics (11th Revision); World Health Organization: Geneva, Switzerland, 2019; Available online: https://icd.who.int (accessed on 3 January 2025).
- Canadian Institute for Health Information. Canadian Coding Standards for Version 2022 ICD-10-CA and CCI; CIHI: Ottawa, ON, Canada, 2022; Available online: https://www.cihi.ca/en/ (accessed on 3 January 2025).
- Centers for Disease Control and Prevention. International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) 2024; National Center for Health Statistics: Atlanta, GA, USA, 2024. Available online: https://www.cdc.gov/nchs/icd/icd-10-cm/index.html (accessed on 3 January 2025).
- Casillas, S.M.; Scholl, L.; Mustaquim, D.; Vivolo-Kantor, A. Analysis of trends and usage of ICD-10-CM discharge diagnosis codes for poisonings by fentanyl, tramadol, and other synthetic narcotics in emergency department data. Addict. Behav. Rep. 2022, 16, 100464. [Google Scholar] [CrossRef] [PubMed]
- Wickham, H.; François, R.; Henry, L.; Müller, K.; Vaughan, D.; dplyr: A Grammar of Data Manipulation (Version 1.1.4) [R Package]. CRAN. 2023. Available online: https://CRAN.R-project.org/package=dplyr (accessed on 3 January 2025).
- Wickham, H.; Vaughan, D.; Girlich, M.; tidyr: Tidy Messy Data (Version 1.3.0) [R Package]. CRAN. 2023. Available online: https://CRAN.R-project.org/package=tidyr (accessed on 3 January 2025).
- Wickham, H.; Henry, L.; purrr: Functional Programming Tools (Version 1.0.2) [R Package]. CRAN. 2023. Available online: https://CRAN.R-project.org/package=purrr (accessed on 3 January 2025).
- Bache, S.; Wickham, H.; magrittr: A Forward-Pipe Operator for R (Version 2.0.3) [R Package]. CRAN. 2022. Available online: https://CRAN.R-project.org/package=magrittr (accessed on 3 January 2025).
- R Core Team. R: A Language and Environment for Statistical Computing; [Computer Software]; R Foundation for Statistical Computing: Vienna, Austria, 2022; Available online: https://www.R-project.org (accessed on 3 January 2025).
- Liu, D.; Choi, K.W.; Lizano, P.; Yuan, W.; Yu, K.-H.; Smoller, J.W.; Kohane, I. Construction of extra-large scale screening tools for risks of severe mental illnesses using real world healthcare data. arXiv 2023. [Google Scholar] [CrossRef]
- De Mattos, B.P.; Mattjie, C.; Ravazio, R.; Barros, R.C.; Grassi-Oliveira, R. Craving for a Robust Methodology: A Systematic Review of Machine Learning Algorithms on Substance-Use Disorders Treatment Outcomes. Int. J. Ment. Health Addict. 2024, 22. [Google Scholar] [CrossRef]
- Acharya, N.; Kar, P.; Ally, M.; Soar, J. Predicting Co-Occurring Mental Health and Substance Use Disorders in Women: An Automated Machine Learning Approach. Appl. Sci. 2024, 14, 1630. [Google Scholar] [CrossRef]
Country | Level | Hospital Data | Physician Data |
---|---|---|---|
Canada ( | Federal |
|
|
Province |
|
| |
Territory |
|
| |
United States ( | Federal |
|
|
State |
|
| |
Territory |
|
|
Group | Size | Visit Date Span | Visit Length | #Hospital | #Physician | SU (Freq) | MH (Freq) | Other (Freq) |
---|---|---|---|---|---|---|---|---|
1 | 10 | 1 January 2024 –31 January 2024 | 1 month | 1 | 2 | F100 (1) | F060 (2) | NA |
2 | 20 | 1 February 2024–31 March 2024 | 2 months | 2 | 4 | T4041 (2) | F063 (4) | J10 (4) |
3 | 30 | 1 April 2024–31 June 2024 | 3 months | 3 | 6 | F120 (3) | F064 (6) | I10 (3) |
4 | 40 | 1 July 2024–31 December 2024 | 6 months | 6 | 12 | F140 (6) | F067 (12) | I10 (6), J10 (12) |
5 | 25 | 1 November 2024–31 December 2024 | 2 months | 3 | 6 | F100 (3) | NA | J10 (6) |
6 | 25 | 1 November 2024–31 December 2024 | 2 months | 2 | 4 | NA | F060 (4) | I10 (2) |
7 | 50 | 1 November 2024–31 December 2024 | 2 months | 1 | 2 | NA | NA | I10 (1), J10 (2) |
ClientID | VisitDate | Diagnostic_H | Diagnostic_P | MHSU_H | Meaning_H | MHSU_P | Meaning_P |
---|---|---|---|---|---|---|---|
001 | 31 January 2024 | F100 | NA | SU | Alcohol | NA | NA |
001 | 15 January 2024 | NA | F060 | NA | NA | MH | Psychotic |
001 | 19 January 2024 | NA | F060 | NA | NA | MH | Psychotic |
011 | 19 February 2024 | T4041 | NA | SU | Fentanyl | NA | NA |
011 | 7 March 2024 | T4041 | NA | SU | Fentanyl | NA | NA |
011 | 14 February 2024 | NA | F063, J10 | NA | NA | MH | Mood, Influenza |
011 | 17 February 2024 | NA | F063, J10 | NA | NA | MH | Mood, Influenza |
011 | 14 March 2024 | NA | F063, J10 | NA | NA | MH | Mood, Influenza |
011 | 10 March 2024 | NA | F063, J10 | NA | NA | MH | Mood, Influenza |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Soltanifar, M.; Lee, C.H. CMHSU: An R Statistical Software Package to Detect Mental Health Status, Substance Use Status, and Their Concurrent Status in the North American Healthcare Administrative Databases. Psychiatry Int. 2025, 6, 50. https://doi.org/10.3390/psychiatryint6020050
Soltanifar M, Lee CH. CMHSU: An R Statistical Software Package to Detect Mental Health Status, Substance Use Status, and Their Concurrent Status in the North American Healthcare Administrative Databases. Psychiatry International. 2025; 6(2):50. https://doi.org/10.3390/psychiatryint6020050
Chicago/Turabian StyleSoltanifar, Mohsen, and Chel Hee Lee. 2025. "CMHSU: An R Statistical Software Package to Detect Mental Health Status, Substance Use Status, and Their Concurrent Status in the North American Healthcare Administrative Databases" Psychiatry International 6, no. 2: 50. https://doi.org/10.3390/psychiatryint6020050
APA StyleSoltanifar, M., & Lee, C. H. (2025). CMHSU: An R Statistical Software Package to Detect Mental Health Status, Substance Use Status, and Their Concurrent Status in the North American Healthcare Administrative Databases. Psychiatry International, 6(2), 50. https://doi.org/10.3390/psychiatryint6020050